Quick Answer
Tvardi Therapeutics, Inc. reported Shares Outstanding of 9.38 million shares for fiscal year 2025.
Tvardi Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 9.38M | +264.4% |
| 2024 | 2.57M | -43.3% |
| 2023 | 4.54M | -91.6% |
| 2022 | 53.80M | +0.6% |
| 2021 | 53.48M | +7.2% |
| 2020 | 49.87M | +6.7% |
| 2019 | 46.72M | +18.1% |
| 2018 | 39.55M | +21.1% |
| 2017 | 32.66M | +19.7% |
| 2016 | 27.30M | +0.2% |
| 2015 | 27.25M | +19.5% |
| 2014 | 22.80M | +431.7% |
| 2013 | 4.29M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 9.38M | -82.9% | +0.1% |
| June 30, 2025 | 9.37M | -82.9% | +514.8% |
| March 31, 2025 | 1.52M | -97.2% | -40.8% |
| December 31, 2024 | 2.57M | -95.3% | -95.3% |
| September 30, 2024 | 54.85M | +0.7% | +0.0% |
| June 30, 2024 | 54.84M | +1.4% | +0.3% |
| March 31, 2024 | 54.67M | +1.3% | +0.3% |
| December 31, 2023 | 54.48M | +1.3% | +0.0% |
- Tvardi Therapeutics, Inc. showed an increase of +264.4% in Shares Outstanding compared to the prior fiscal year.
- Over the 2013–2025 period, Tvardi Therapeutics, Inc.’s shares outstanding has grown by 118.8% (from 4.29 million shares to 9.38 million shares).
- The most recent figure is from Tvardi Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: